Company intelligence
The Fibroid Foundation
We are the voice of women with uterine fibroids.
About The Fibroid Foundation
As the premier global community of fibroids patients, our mission is to amplify the voice of women living with fibroids. We intentionally create and support initiatives to find a cure for fibroids by advocating for ongoing funding of patient-sensitive fibroids research. We strive to erase the ‘Stigma of Silence’ around menstrual health and minimize treatment disparities with layered patient support by creating and supporting initiatives to find a #CUREforFibroids. Our innovative programs, strategic initiatives, and powerful partnerships directly reach patients in their daily lives and healthcare providers in their daily practice. We take a multi-faceted approach to fibroid education. By developing a collaborative partnership with fellow patients and healthcare providers, we foster a supportive relationship where informed women regularly have proactive conversations with trusted providers. Our unique insights layered with a unique mix of digital and in-person outreach drives exponential change as a patient-founded organization. Please visit www.fibroidfoundation.org to learn more about The Fibroid Foundation.
Verified activity
Signals from The Fibroid Foundation
3 published signals
Research & Knowledge
The Fibroid Foundation highlighted that Sound Wave Technology is expanding HIFU as a non-surgical fibroid treatment in clinics across Lagos and Abuja, with a cost of roughly NGN 1.5-2.5 million in Nigeria's private sector.
Reported by The Fibroid Foundation
Research & Knowledge
The Fibroid Foundation announced a £10,000 grant from London Freemasons to fund a pilot study at King's College Hospital investigating whether uterine fibroids increase the risk of venous thromboembolism (VTE) or blood clots in the veins, led by Dr. Obianuju Nzelu.
Reported by The Fibroid Foundation
Research & Knowledge
The Fibroid Foundation published research indicating that black women are diagnosed with uterine fibroids at two to three times the rate of white women, often earlier and more severely.
Reported by The Fibroid Foundation